Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (27983)	2/7/1999 11:17:00 PM
From: LLCF	Respond to of 32384

Mudcat... I said: <Since in the long run it makes negligible difference to the present value of the company whether approval was Dec. 4, or Feb 4, only IF the drug gets approval.> To which you answered: <I hate to break this to you but it is not a negligible difference. It would have greatly improved the chances of Lgnd turning a profit in 1999 if the approvals came Dec4 vs Feb 4. > The first part of your statement just states that my statement is not true [in a condescending way]. The second part of your statement is true but has little to do with my assertion. So I'll restate my assertion to the rest of the thread: "It makes negligible difference to the present value of the company whether approval was Dec. 4, or Feb 4, only IF the drug gets approval." And add... please let me know the next time you know of a company that will be getting its first approval but it will be late. DAK